Literature DB >> 34273018

Changes in the quality of life score following preoperative chemotherapy in elderly patients with esophageal cancer.

R Shimada1, M Yamasaki2, K Tanaka3, T Makino3, Y Doki3, K Umeshita4.   

Abstract

BACKGROUND: Various functions in elderly patients with esophageal cancer deteriorate easily and their quality of life can be adversely affected by treatment. The age groups covered in previous studies are wide, and the impact on the elderly individuals is unknown. This study examined changes in quality of life scores after preoperative chemotherapy to clarify aspects of physical, psychological, and social quality of life in elderly patients with esophageal cancer.
METHODS: Thirty-six patients aged over 65 years, who were scheduled to undergo preoperative chemotherapy for esophageal cancer surgery, were enrolled. The survey questionnaire comprised the EORTC QLQ-C30 Japanese Language Version, EORTC QLQ-OES 18 Japanese Language Version, and G8. The surveys were conducted before chemotherapy (pre-CT) and after chemotherapy (post-CT).
RESULTS: In the functional scale of QLQ-C 30, physical functioning decreased significantly, while emotional functioning increased significantly post-CT (p = 0.021, p = 0.030, respectively). Global health status was not changed. In QLQ-OES18, the mean symptom scale score decreased significantly for dysphagia, trouble swallowing saliva, choking, eating, reflux, and pain post-CT (p = 0.014, p = 0.034, p = 0.033, p = 0.022, p = 0.026, p = 0.016, respectively). The mean G8 score decreased significantly from 11.7 to 10.7 (p = 0.022) post-CT, but the proportion of patients with dysfunction decreased.
CONCLUSIONS: Quality of life scores of elderly patients with esophageal cancer who received preoperative chemotherapy decreased in terms of physical function but improved in terms of esophageal cancer symptoms and mental function. Our results suggest that alleviation of symptoms contributed to the improvements in mental health.
© 2021. The Japan Esophageal Society.

Entities:  

Keywords:  Elderly; Esophageal cancer; Preoperative chemotherapy; Quality of life scores

Mesh:

Year:  2021        PMID: 34273018     DOI: 10.1007/s10388-021-00862-w

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  4 in total

1.  Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study.

Authors:  B F Kingma; P Rauwerdink; H J F Brenkman; J P Ruurda; R van Hillegersberg
Journal:  J Cancer Surviv       Date:  2019-12-17       Impact factor: 4.442

Review 2.  Psychological support of esophageal cancer patient?

Authors:  Eleonora Pinto; Francesco Cavallin; Marco Scarpa
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Core information set for oesophageal cancer surgery.

Authors:  J M Blazeby; R Macefield; N S Blencowe; M Jacobs; A G K McNair; M Sprangers; S T Brookes
Journal:  Br J Surg       Date:  2015-05-18       Impact factor: 6.939

4.  Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

Authors:  Pierre Soubeyran; Carine Bellera; Jean Goyard; Damien Heitz; Hervé Curé; Hubert Rousselot; Gilles Albrand; Véronique Servent; Olivier Saint Jean; Isabelle van Praagh; Jean-Emmanuel Kurtz; Stéphane Périn; Jean-Luc Verhaeghe; Catherine Terret; Christophe Desauw; Véronique Girre; Cécile Mertens; Simone Mathoulin-Pélissier; Muriel Rainfray
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

  4 in total
  2 in total

Review 1.  Management of elderly patients with esophageal squamous cell cancer.

Authors:  Yasuo Hamamoto; Kentaro Murakami; Ken Kato; Yuko Kitagawa
Journal:  Jpn J Clin Oncol       Date:  2022-08-05       Impact factor: 2.925

2.  Study on the Application Value of Concurrent Chemoradiotherapy and Clinical Nursing Pathway for Postoperative Patients with Esophageal Cancer.

Authors:  Jinglei Yang; Xianzhong Zhang; Guangrong Yang; Xiufang Mi; Yang Zhang; Yingzhong Sui
Journal:  J Oncol       Date:  2022-09-15       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.